within Pharmacolibrary.Drugs.ATC.V;

model V09HX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 185 / 1000000,
    adminCount     = 1,
    Vd             = 0.013900000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Gallium (67Ga) citrate is a radiopharmaceutical agent used primarily for diagnostic imaging in nuclear medicine, particularly for the localization of inflammatory lesions and certain malignancies such as lymphoma. It is not used for therapeutic purposes and is approved for use as a diagnostic imaging agent.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are generally based on adult patients undergoing diagnostic imaging investigations. Data references intravenous administration in typical clinical practice.</p><h4>References</h4><ol><li><p>Shanthly, N, et al., &amp; Thakur, ML (2006). 99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation. <i>The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...</i> 50(2) 104–112. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16770300/&quot;>https://pubmed.ncbi.nlm.nih.gov/16770300</a></p></li><li><p>Konuk, O, et al., &amp; Hasanreisoglu, B (2002). Orbital gallium-67 scintigraphy in Graves&#x27; ophthalmopathy. <i>Thyroid : official journal of the American Thyroid Association</i> 12(7) 603–608. DOI:<a href=&quot;https://doi.org/10.1089/105072502320288465&quot;>10.1089/105072502320288465</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12193305/&quot;>https://pubmed.ncbi.nlm.nih.gov/12193305</a></p></li><li><p>Shiomi, S, et al., &amp; Ochi, H (1997). Changes in results of Gallium-67-citrate scanning after interferon therapy for chronic hepatitis C. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 38(2) 216–219. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9025739/&quot;>https://pubmed.ncbi.nlm.nih.gov/9025739</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09HX01;
